No Data
No Data
Renal Research Institute and Karolinska Institutet Announce Chronic Kidney Disease Management Symposium, Highlighting New Therapeutics
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Fresenius Medical Care Annual General Meeting: Company Makes Significant Progress in Its Transformation Efforts and Confirms Its Ambitious 2024 Growth Targets
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2024 Earnings Call Transcript
Analysts' Top Healthcare Picks: Fresenius Medical Care AG & Co. KGaA (GB:0H9X), Omega Therapeutics (OMGA)
6-K: Report of foreign private issuer (related to financial reporting)
Unlock the Full List